Weekly Roundup - PHARMA - 28 April 2025

Описание: 🚀 Weekly Roundup - PHARMA - 28 April 2025

🚀 Stay in the lead with last week's top pharmaceutical industry highlights! 📈💊 

Click here to read more ➡   / weekly-roundup-pharma-28-april-2025-kstrat...  

#FDAApprovals
🔊 Sanofi and Regeneron’s Dupixent Approved by FDA for Chronic Spontaneous Urticaria in Patients 12 and Older
🔊 FDA Approves Penpulimab for First-Line and Post-Chemo Treatment of Non-Keratinizing Nasopharyngeal Carcinoma
🔊 Vertex’s Alyftrek Gains FDA Approval for Once-Daily Cystic Fibrosis Treatment
🔊 Lupin Wins FDA Approval for Generic Tolvaptan in Autosomal Dominant Polycystic Kidney Disease

#Deal
🔊 Merck KGaA in $3.5B Talks to Acquire SpringWorks, Maker of Desmoid Tumor Drug Ogsiveo
🔊 Mosaic Therapeutics Secures ASTX029 and ASTX295 from Astex for Precision Cancer Treatments
🔊 Eli Lilly and BigHat Biosciences Launch AI-Powered Antibody Discovery Collaboration in Oncology
🔊 Sanofi Returns SAR443579 (CD123 NK Cell Engager) to Innate Pharma, Shifting Focus to Autoimmune Diseases

#FDASubmission
🔊 AbbVie Submits FDA Application for TrenibotE to Treat Moderate to Severe Glabellar Lines

#TrialUpdate
🔊 FDA Clears Aclaris' ATI-052 Bispecific Antibody for Immuno-Inflammatory Trial
🔊 Calidi Biotherapeutics Receives FDA IND Clearance for CLD-201 in Solid Tumor Treatment
🔊 Eli Lilly’s Orforglipron Pill Shows Promise for Type 2 Diabetes and Weight Loss, FDA Submission Planned